BPC157 & TB500 Peptide Pen – Wolverine Stack Healing Blend

BPC157 & TB500 Pen is a convenient, pre-filled injectable delivery system containing a high-purity research peptide blend of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment), two synthetic peptides extensively studied in preclinical models for their complementary roles in tissue regeneration, wound healing, and recovery processes.

This popular combination — often referred to in research contexts as the “Wolverine Stack” — is investigated for synergistic effects on promoting angiogenesis, reducing inflammation, enhancing cell migration, supporting tendon/ligament/muscle repair, and accelerating overall tissue recovery in laboratory settings.

Key Features

• Pre-filled multi-dose pen format — Pre-mixed and ready-to-use (no reconstitution, manual drawing, or mixing required), reducing preparation errors and variability in experimental protocols
• Total peptide content — Commonly 20 mg per pen (e.g., 10 mg BPC-157 + 10 mg TB-500; variations like 15 mg or 40 mg total may exist depending on supplier)
• Concentration — Typically formulated for precise dosing (e.g., ~10 mg/mL in bacteriostatic water premixed solution)
• Dosing mechanism — Adjustable dose selector (e.g., click-based for incremental microgram delivery; research protocols often explore 250–500 mcg BPC-157 equivalent daily or 2–5 mg TB-500 weekly equivalents, adjusted per study needs)
• Injection volume — Small subcutaneous doses (typically 0.1–0.5 mL per administration)
• Subcutaneous administration — Designed for SubQ injection studies, supporting systemic distribution in research models
• Pen design — Includes dose window/viewer, injection button, solution visibility chamber, and safety features for accurate, repeatable use in controlled lab environments
• Appearance — Clear, sterile solution (always inspect for clarity, particles, or discoloration before use in procedures)